These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28492501)

  • 1. Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations.
    Troisi J; Pierri L; Landolfi A; Marciano F; Bisogno A; Belmonte F; Palladino C; Guercio Nuzio S; Campiglia P; Vajro P
    Nutrients; 2017 May; 9(5):. PubMed ID: 28492501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome.
    Troisi J; Belmonte F; Bisogno A; Pierri L; Colucci A; Scala G; Cavallo P; Mandato C; Di Nuzzi A; Di Michele L; Delli Bovi AP; Guercio Nuzio S; Vajro P
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30691143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.
    Belei O; Olariu L; Dobrescu A; Marcovici T; Marginean O
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1161-1168. PubMed ID: 28988228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.
    Miccheli A; Capuani G; Marini F; Tomassini A; Praticò G; Ceccarelli S; Gnani D; Baviera G; Alisi A; Putignani L; Nobili V
    Int J Obes (Lond); 2015 Jul; 39(7):1118-25. PubMed ID: 25809828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
    Nier A; Brandt A; Conzelmann IB; Özel Y; Bergheim I
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children.
    Luo J; Luo M; Kaminga AC; Wei J; Dai W; Peng Y; Zhao K; Duan Y; Xiao X; Ouyang S; Yao Z; Liu Y; Pan X
    Microbiol Spectr; 2024 Apr; 12(4):e0523022. PubMed ID: 38445874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement.
    Guercio Nuzio S; Di Stasi M; Pierri L; Troisi J; Poeta M; Bisogno A; Belmonte F; Tripodi M; Di Salvio D; Massa G; Savastano R; Cavallo P; Boffardi M; Ziegenhardt D; Bergheim I; Mandato C; Vajro P
    Pediatr Obes; 2017 Dec; 12(6):446-452. PubMed ID: 27350543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease.
    Dong S; Zhan ZY; Cao HY; Wu C; Bian YQ; Li JY; Cheng GH; Liu P; Sun MY
    World J Gastroenterol; 2017 Apr; 23(15):2771-2784. PubMed ID: 28487615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approach.
    Feldman A; Eder SK; Felder TK; Paulweber B; Zandanell S; Stechemesser L; Schranz M; Strebinger G; Huber-Schönauer U; Niederseer D; Patsch W; Weghuber D; Tevini J; Datz C; Aigner E
    Diabetes Metab; 2019 Apr; 45(2):132-139. PubMed ID: 30266576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
    Gudan A; Kozłowska-Petriczko K; Wunsch E; Bodnarczuk T; Stachowska E
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
    Sayın O; Tokgöz Y; Arslan N
    J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease.
    Goffredo M; Santoro N; Tricò D; Giannini C; D'Adamo E; Zhao H; Peng G; Yu X; Lam TT; Pierpont B; Caprio S; Herzog RI
    Nutrients; 2017 Jun; 9(7):. PubMed ID: 28640216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of nonalcoholic fatty liver disease with small intestine bacterial overgrowth in obese children.
    Stepanov YM; Zavhorodnia NY; Yagmur VB; Lukianenko OY; Zygalo EV
    Wiad Lek; 2019; 72(3):350-356. PubMed ID: 31050979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
    Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
    World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.